- Home
- TXMD vs BEAT Comparison
TXMD vs BEAT Comparison
Compare TXMD & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXMD | BEAT |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 27.7M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TXMD | BEAT |
|---|---|---|
| Price | $2.18 | $0.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 30.3K | ★ 298.3K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.68 | 15.07 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,761,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | $109.00 | ★ N/A |
| Revenue Growth | ★ 35.25 | N/A |
| 52 Week Low | $0.99 | $0.39 |
| 52 Week High | $2.95 | $4.00 |
Technical Indicators
Market Signals| Indicator | TXMD | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 38.51 |
| Support Level | $2.07 | $0.39 |
| Resistance Level | $2.30 | $0.52 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 45.83 | 35.31 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.